| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Psychosomatic Medicine, Vol 48, Issue 3 278-282, Copyright © 1986 by American Psychosomatic Society
ORIGINAL ARTICLES |
RS Surwit, JA McCubbin, CM Kuhn, D McGee, D Gerstenfeld and MN Feinglos
We have shown that the C57BL/6J ob/ob (obese) mouse, a commonly used model of type II diabetes mellitus, is not in fact consistently hyperglycemic except when exposed to environmental stress. In an attempt to modify stress hyperglycemia in this animal, we administered either a 5 mg/kg dose of the benzodiazepine alprazolam or vehicle (propylene glycol) intraperitoneally to both obese mice and their lean littermates prior to a rest and a stress period. Alprazolam modified the hyperglycemic effect of stress only in the obese mice. Alprazolam significantly reduced plasma corticosterone in obese animals at rest and following stress. In addition, alprazolam significantly increased plasma insulin in all animals at rest and following stress. These data suggest a possible role for benzodiazepines in the modification of stress hyperglycemia in type II diabetes mellitus.
This article has been cited by other articles:
 |
|
 |
|
  A. M. Delamater, A. M. Jacobson, B. Anderson, D. Cox, L. Fisher, P. Lustman, R. Rubin, and T. Wysocki Psychosocial Therapies in Diabetes: Report of the Psychosocial Therapies Working Group Diabetes Care, July 1, 2001; 24(7): 1286 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A.L. Van Tilburg, C. C. McCaskill, J. D. Lane, C. L. Edwards, A. Bethel, M. N. Feinglos, and R. S. Surwit Depressed Mood Is a Factor in Glycemic Control in Type 1 Diabetes Psychosom Med, July 1, 2001; 63(4): 551 - 555. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
